Surface Ophthalmics Announces $25 Million Private Round of Fundraising

Surface Ophthalmics Announces $25 Million Private Round of Fundraising |[21-July-2021]| Proceeds from the capital raise will help to support and advance Surface’s ongoing clinical programs in ocular diseases PLEASANTON, Calif., Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced it has secured gross proceeds of approximately $25 million in a private placement of preferred stock, at a purchase price of $4.50 per share. Investors in this round of financing included both new and existing investors made up of institutional, healthcare-focused, and other accredited investors, including members of …

Read the source article at biospace.com
2021-07-21 04:00:00